These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
64 related items for PubMed ID: 19591040
1. Antigenicity of a type A influenza virus through comparison of hemagglutination inhibition and mass spectrometry immunoassays. Schwahn AB, Downard KM. J Immunoassay Immunochem; 2009; 30(3):245-61. PubMed ID: 19591040 [Abstract] [Full Text] [Related]
2. Antigenic characterisation of H3N2 subtypes of the influenza virus by mass spectrometry. Morrissey B, Streamer M, Downard KM. J Virol Methods; 2007 Nov; 145(2):106-14. PubMed ID: 17588679 [Abstract] [Full Text] [Related]
3. Kinetics of antigen-antibody interactions employing a MALDI mass spectrometry immunoassay. Morrissey B, Downard KM. Anal Chem; 2008 Oct 15; 80(20):7720-6. PubMed ID: 18816071 [Abstract] [Full Text] [Related]
4. A proteomics approach to survey the antigenicity of the influenza virus by mass spectrometry. Morrissey B, Downard KM. Proteomics; 2006 Apr 15; 6(7):2034-41. PubMed ID: 16502471 [Abstract] [Full Text] [Related]
8. [Peptide mapping of the monoclonal antibodies against the heavy chain hemagglutinin from influenza virus H3N2]. Mazurkova NA, Isaeva EI, Podcherniaeva RIa. Mol Gen Mikrobiol Virusol; 2006 Apr 15; (4):19-23. PubMed ID: 17094654 [Abstract] [Full Text] [Related]
9. Highly conserved sequences for human neutralization epitope on hemagglutinin of influenza A viruses H3N2, H1N1 and H5N1: Implication for human monoclonal antibody recognition. Yamashita A, Kawashita N, Kubota-Koketsu R, Inoue Y, Watanabe Y, Ibrahim MS, Ideno S, Yunoki M, Okuno Y, Takagi T, Yasunaga T, Ikuta K. Biochem Biophys Res Commun; 2010 Mar 19; 393(4):614-8. PubMed ID: 20152806 [Abstract] [Full Text] [Related]
10. Evaluation of twenty rapid antigen tests for the detection of human influenza A H5N1, H3N2, H1N1, and B viruses. Taylor J, McPhie K, Druce J, Birch C, Dwyer DE. J Med Virol; 2009 Nov 19; 81(11):1918-22. PubMed ID: 19774693 [Abstract] [Full Text] [Related]
12. The Eurocine L3 adjuvants with subunit influenza antigens induce protective immunity in mice after intranasal vaccination. Petersson P, Hedenskog M, Alves D, Brytting M, Schröder U, Linde A, Lundkvist A. Vaccine; 2010 Sep 07; 28(39):6491-7. PubMed ID: 20637767 [Abstract] [Full Text] [Related]
13. Inhibition of influenza virus haemolytic and haemagglutination activities by monoclonal antibodies to haemagglutinin glycopolypeptides HA1 and HA2. Kostolanský F, Styk B, Russ G. Acta Virol; 1989 Dec 07; 33(6):504-12. PubMed ID: 2576592 [Abstract] [Full Text] [Related]
14. [Antigenic and genetic study of influenza virus circulated in China in 2006]. Zhang Y, Zhao X, Guo JF, Wei HJ, Cheng YH, Li XW, Xu CL, Guo YJ, Shu YL. Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2007 Dec 07; 21(4):304-6. PubMed ID: 18322584 [Abstract] [Full Text] [Related]
15. An alternative method for preparation of pandemic influenza strain-specific antibody for vaccine potency determination. Schmeisser F, Vodeiko GM, Lugovtsev VY, Stout RR, Weir JP. Vaccine; 2010 Mar 11; 28(12):2442-9. PubMed ID: 20074687 [Abstract] [Full Text] [Related]